These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check the appropriate box:
|
||
|
☐
|
|
Preliminary proxy statement
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☒
|
|
Definitive proxy statement
|
|
☐
|
|
Definitive additional materials
|
|
☐
|
|
Soliciting material pursuant to § 240.14a-12
|
|
|
☒
|
|
No fee required.
|
||
|
|
|
||||
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
|
Total fee paid:
|
|
|
|
||||
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
||
|
|
|
||||
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
|
||
|
|
|
|
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
|
||||
|
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
|
(4)
|
|
Date Filed:
|
|
2019 Proxy Statement |
Summary
|
|
| Date and Time |
|
|
Meeting Location |
|
|
Record Date
|
|
Voting
|
|
|
| Tuesday, May 14, 2019 at 9:30 a.m. |
|
Vishay Intertechnology Inc.
World Headquarters
63 Lancaster Ave.
Malvern, PA 19355
|
|
March 18, 2019
|
Each share of common stock will be entitled to one vote and each share of Class B common stock will be entitled to 10 votes with respect to each matter to be voted on at the annual meeting.
|
|||||
|
PROPOSAL
|
BOARD
RECOMMENDATION
|
PAGE REFERENCE
|
|
|
①
|
The election of three directors to hold office until 2022 and one director to hold office until 2020
|
FOR ALL
|
17
|
|
②
|
The ratification of our independent registered public accounting firm
|
FOR
|
20 |
|
③
|
The advisory vote on executive compensation
|
FOR
|
59 |
|
④
|
The advisory vote on the frequency of the advisory vote on executive compensation
|
ANNUALLY
|
60 |
|
NAME
|
AGE
|
DIRECTOR SINCE
|
TERM EXPIRING
|
OCCUPATION
|
QUALIFICATIONS
|
INDEPENDENT
|
COMMITTEE OF THE BOARD
|
|||
|
E
|
A
|
NCG
|
CC
|
|||||||
|
Dr. Gerald Paul
|
70
|
1993
|
2022
|
President and CEO, Vishay Intertechnology, Inc.
|
Leadership,
Electronics Industry, Company, Global |
-
|
M
|
|||
|
Timothy V. Talbert
|
72
|
2013
|
2022
|
Retired Sr. VP Credit and Originations, Lease Corporation of America ("LCA"); Retired President, LCA Bank Corporation
|
Leadership, Finance, Compliance
|
✓
|
C
|
|||
|
Thomas C.
Wertheimer |
78
|
2004
|
2022
|
Accounting Consultant,
previously partner of
PricewaterhouseCoopers LLP
|
Leadership, Finance, Compliance
|
✓
|
C (FE) |
|
M
|
|
|
Michael Cody
|
69
|
2018
|
2020
|
Retired VP - Business Development, Raytheon Company
|
Leadership, Complementary Industry, Finance, M&A
|
✓
|
M# | |||
|
E
|
Executive Committee
|
|
A
|
Audit Committee
|
|
NCG
|
Nominating and Corporate Governance Committee
|
|
CC
|
Compensation Committee
|
|
C
|
Committee Chair
|
|
M
|
Committee Member
|
|
(FE)
|
Financial Expert
|
| # | Appointed to committee on February 28, 2019 |
|
2019 Proxy Statement |
Summary
|
|
|
A market-competitive
base salary
|
|
Cash incentive compensation
a portion of which is based on Company-wide achievements and another portion of which is based on personal achievements, with a cap to discourage inappropriate risk-taking
|
|
Equity-based compensation
of which 75% vests only upon the achievement of three-year performance metrics and the balance of which vests on January 1 of the third year following the grant date
|
|
|
|
|
|
|
|
Deferred cash compensation and retirement benefits
generally payable at retirement / termination of employment
|
|
Deferred equity compensation
in the form of phantom stock units payable at retirement / termination of employment for certain of our Named Executive Officers
|
|
Perquisites and other personal benefits
|
|
2019 Proxy Statement |
Summary
|
|
|
Board Governance
|
|
|
•
|
Separate Executive Chairman of the Board and Chief Executive Officer;
|
|
|
•
|
All directors attend at least 75% of all meetings on an annual basis;
|
|
|
•
|
Significant stock ownership guidelines for directors, equal to five times the value of their annual cash retainer (subject to a five year phase-in);
|
|
|
•
|
Annual self-evaluations of Board as a whole;
|
|
|
•
|
No restrictions on directors' access to management or employees; and
|
|
|
•
|
Board oversees the Company's strategic priorities and risk management.
|
|
|
|
|
|
|
Committee Governance
|
|
|
•
|
Audit Committee composed entirely of independent directors;
|
|
|
•
|
Compensation Committee composed entirely of independent directors; and
|
|
|
•
|
Nominating and Corporate Governance Committee composed entirely of independent directors.
|
|
|
|
|
|
|
Responsible Compensation and Planning
|
|
|
•
|
Cap on bonuses;
|
|
|
•
|
Nominating and Corporate Governance Committee has primary responsibility for Chief Executive Officer and key executive succession planning; and
|
|
|
•
|
Succession and executive development are discussed with the Chief Executive Officer, as well as without the Chief Executive Officer present in executive sessions.
|
|
|
|
|
|
|
Independent Experience
|
|
|
•
|
Highly-experienced directors in a wide range of industries;
|
|
|
•
|
All directors possess a significant level of knowledge regarding Vishay and our industry;
|
|
|
•
|
All of our current directors received a majority of the votes cast by holders of common stock who are unaffiliated with the current Class B stockholders when they last stood for election at an annual meeting of stockholders, other than Mr. Cody, who has not previously stood for election;
|
|
|
•
|
Independent directors meet in regularly scheduled executive sessions; and when required, in special executive sessions;
|
|
|
•
|
Only four directors serving on the boards of other public companies; and
|
|
|
•
|
No director serving on more than one other public company board.
|
|
|
|
|
|
|
Audit Integrity
|
|
|
•
|
Auditor is independent;
|
|
|
•
|
Non-audit fees are reasonable relative to audit and audit-related fees; and
|
|
|
•
|
Lead audit partner must be rotated after five years, which provides the Company the benefit of new thinking and approaches. | |
|
2019 Proxy Statement |
Directors
|
|
| COMMITTEE OF THE BOARD | |||||||||||||||||
|
NAME
|
|
AGE
|
|
DIRECTOR SINCE
|
|
CLASS / TERM EXPIRING
|
|
OCCUPATION
|
|
QUALIFICATIONS
|
|
INDEPENDENT
|
|
E
|
A
|
NCG
|
CC
|
|
Dr. Gerald Paul
|
|
70
|
|
1993
|
|
I / 2022*
|
|
President and CEO, Vishay Intertechnology, Inc.
|
|
Leadership, Electronics Industry, Company, Global
|
|
|
|
M
|
|
|
|
|
Timothy V. Talbert
|
|
72
|
|
2013
|
|
I / 2022*
|
|
Retired Sr. VP Credit and Originations, Lease Corporation of America ("LCA"); Retired President, LCA Bank Corporation
|
|
Leadership, Finance, Compliance
|
|
✓
|
|
|
|
|
C
|
|
Thomas C. Wertheimer
|
|
78
|
|
2004
|
|
I / 2022*
|
|
Accounting Consultant, previously partner of PricewaterhouseCoopers LLP
|
|
Leadership, Finance, Compliance
|
|
✓
|
|
|
C (FE)
|
|
M
|
| Michael Cody | 69 | 2018 | II / 2020* | Retired VP - Corporate Development, Raytheon Company | Leadership, Complementary Industry, Finance, M&A |
✓
|
M# | ||||||||||
|
Frank Dieter Maier**
|
81
|
2010 | I / 2019** |
Retired Managing Director, TEMIC GmbH
|
Leadership, Electronics Industry, Global
|
✓
|
M
|
M | |||||||||
|
Dr. Abraham Ludomirski
|
|
67
|
|
2003
|
|
II / 2020
|
|
Founder and Managing Director of Vitalife Fund
|
|
Leadership, Complementary Industry, Finance, Global
|
|
✓
|
|
|
|
C
|
M
|
|
Ronald Ruzic
|
|
80
|
|
2009
|
|
II / 2020
|
|
Retired Group President, BorgWarner Automotive, Inc.
|
|
Leadership, Complementary Industry, Global
|
|
✓
|
|
|
M
|
M
|
|
|
Raanan Zilberman
|
|
58
|
|
2017
|
|
II / 2020
|
|
Former President and CEO, Caesarstone, Ltd.
|
|
Leadership, Electronics Industry, Company, Global
|
|
✓
|
|
|
|
M#
|
|
|
Marc Zandman
|
|
57
|
|
2001
|
|
III / 2021
|
|
Executive Chairman of the Board, Chief Business Development Officer, Vishay Intertechnology, Inc.
|
|
Leadership, Electronics Industry, Company, Global
|
|
|
|
C
|
|
|
|
|
Ruta Zandman
|
|
81
|
|
2001
|
|
III / 2021
|
|
Private Stockholder
|
|
Leadership, Electronics Industry, Company, Global
|
|
|
|
|
|
|
|
|
Ziv Shoshani
|
|
52
|
|
2001
|
|
III / 2021
|
|
President and CEO, Vishay Precision Group, Inc.
|
|
Leadership, Electronics Industry, Company, Global
|
|
|
|
|
|
|
|
|
*:
|
|
Nominees for election at 2019 annual meeting
|
| **: | Mr. Maier is not seeking re-election. | |
|
E:
|
|
Executive Committee
|
|
A:
|
|
Audit Committee
|
|
NCG:
|
|
Nominating and Corporate Governance Committee
|
|
CC:
|
|
Compensation Committee
|
|
C:
|
|
Committee Chair
|
|
M:
|
|
Committee Member
|
|
(FE):
|
|
Financial Expert
|
| #: | Appointed to committee on February 28, 2019 |
|
2019 Proxy Statement |
Directors
|
|
|
Dr. Gerald Paul
was appointed Chief Executive Officer effective January 1, 2005. Dr. Paul has served as a Director of the Company since 1993, and has been President of the Company since March 1998. Dr. Paul also was Chief Operating Officer from 1996 to 2006. Dr. Paul previously was an Executive Vice President of the Company from 1996 to 1998, and President of Vishay Electronic Components, Europe from 1994 to 1996. Dr. Paul has been Managing Director of Vishay Electronic GmbH, a subsidiary of the Company, since 1991. Dr. Paul has been employed by Vishay and a predecessor company since 1978. Dr. Paul possesses extensive experience with the Company, has senior responsibilities for our overall business, and has been instrumental in promoting our strategic advances. His in-depth knowledge of our operations includes the integration of acquired companies and a proven understanding of the challenges facing the Company in all aspects of the business cycle.
|
|
|
|
|
|
|
Timothy V. Talbert
retired in 2018 from his positions as Senior Vice President of Credit and Originations for Lease Corporation of America ("LCA"), a national equipment lessor (since July 2000) and President of the LCA Bank Corporation, a bank that augments LCA's funding capacity (since its founding in January 2006). Previously, Mr. Talbert was Senior Vice President and Director of Asset Based Lending and Equipment Leasing of Huntington National Bank from 1997 to 2000; and prior to that, served in a variety of positions with Comerica Bank for more than 25 years. Mr. Talbert previously served on the board of directors and was a member of the audit committee of Siliconix incorporated, a NASDAQ-listed manufacturer of power semiconductors of which the Company owned an 80.4% interest, from 2001 until the Company acquired the noncontrolling interests in 2005. Mr. Talbert has also served on the board of Vishay Precision Group since it was spun off from the Company in 2010. Mr. Talbert's previous and current service as a director of publicly traded companies allows him to bring an important perspective to the Board. Additionally, Mr. Talbert's service as the president of a federally regulated institution gives him relevant understanding of compliance with complex regulations and current accounting rules which add invaluable expertise to our Board.
|
|
|
|
|
|
|
Thomas C. Wertheimer
is an independent financial and accounting consultant. Prior to his retirement in 2000, he was a senior audit partner with the accounting firm of PricewaterhouseCoopers LLP and its predecessor Coopers & Lybrand LLP. In this capacity, Mr. Wertheimer was responsible for the audits of major U.S. and international public companies and was also a technical consulting partner in the firm's national office. From 2003 until 2007, Mr. Wertheimer was a consultant for the Public Company Accounting Oversight Board. He was also a director of Fiserv, Inc., an information management and service provider, until May 2017, and was also previously a director of Xinyuan Real Estate Co., Ltd., a residential real estate developer in China, through December 31, 2014. Mr. Wertheimer brings to the Board extensive knowledge and experience in accounting, finance, risk management and public company oversight.
|
|
2019 Proxy Statement |
Directors
|
|
|
Michael Cody
was, from 2009 until his retirement in 2017, Vice President of Corporate Development at Raytheon Company, a technology company specializing in defense, civil government and cybersecurity solutions. At Raytheon, Mr. Cody was responsible for overseeing all merger and acquisition activity, where he executed 18 transactions aggregating in excess of $4.3 billion in transaction value. From 2007-2009, Mr. Cody was a founding partner of Meadowood Capital LLC, a private equity firm focused on technology companies. From 1997 to 2007, Mr. Cody was Vice President of Corporate Development at EMC Corporation, a developer and provider of information infrastructure technology. Mr. Cody has previously served on the boards of Safeguard Scientific, Inc., a NYSE listed private equity and venture capital firm; and MTI Ltd., a private company in the UK specializing in cloud, security, and infrastructure. Mr. Cody brings to the Board extensive knowledge and experience with mergers and acquisitions as well as experience with technology and defense businesses. Additionally, Mr. Cody's experience as a director of publicly traded and private companies allows him to bring an important perspective to the Board.
|
|
Dr. Abraham Ludomirski
is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He is also the Chairman of the Board of POCARED Diagnostics, Ltd., an Israeli high-tech company specializing in miniature electronics and optical and video systems, and serves on the board of directors of Recro Pharma, Inc., Sensible Medical Innovations Ltd., Trig Medical, ENDOSPAN Ltd., and DIR Technologies. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski's work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies.
|
|
|
Ronald Ruzic was, prior to his retirement, Executive Vice President of BorgWarner Inc. since 1992 and Group President of BorgWarner Automotive Inc. since 1989. Previously, he held various executive positions with BorgWarner. After joining BorgWarner in 1968 as a senior manufacturing engineer for its subsidiary Morse Chain, Mr. Ruzic progressed through engineering and management positions and managed various BorgWarner operations in the UK, Italy, Mexico, Germany and the United States. Mr. Ruzic formerly served on the boards of directors of Guilford Mills Inc., AG Kühnle Kopp & Kausch, Magneti Marelli S.p.A. and Citation Corporation. Mr. Ruzic brings to the Board many years' experience with the management and technical challenges facing complex, multi-national businesses such as Vishay. | |
|
Raanan Zilberman was Chief Executive Officer of Caesarstone Ltd., a NASDAQ-listed manufacturer of high quality engineered quartz surfaces, from February 2017 to March 2018. Prior to that, Mr. Zilberman served as Chief Executive Officer of Eden Springs, a Swiss-based leading provider of water and coffee services to European workplaces; Chief Executive Officer of Danone Springs, a joint venture between Danone and Eden Springs, with a European-wide water production and distribution footprint; Chief Executive Officer of Tedea Huntleigh, a company listed on the Tel Aviv Stock Exchange engaged in the production and marketing of electromechanical sensors; and Chief Operating Officer of Tadiran Appliances, a manufacturer of air conditioners and refrigerators. Tedea Huntleigh was acquired by Vishay in 2002, and Mr. Zilberman was President of Vishay's transducers business from 2002 to 2004. Mr. Zilberman's previous service as a Chief Executive Officer of publicly traded companies will allow him to bring an important perspective to the Board. Additionally, his past experience with Vishay provides him with valuable insight of our business and operations. |
|
2019 Proxy Statement |
Directors
|
|
|
Marc Zandman
is Executive Chairman of the Board of Directors, the Chief Business Development Officer, and President of Vishay Israel Ltd. Mr. Zandman has been President of Vishay Israel Ltd. since 1998 and a Director of Vishay since 2001. Mr. Zandman was Vice Chairman of the Board from 2003 to June 2011, Chief Administration Officer from 2007 to June 2011, and Group Vice President of Vishay Measurements Group from 2002 to 2004. Mr. Zandman has served in various other capacities with Vishay since 1984. Mr. Zandman has served as the non-executive Chairman of the Board of Directors of Vishay Precision Group since the spin-off from Vishay on July 6, 2010. He is the son of the late Dr. Felix Zandman, founder and Vishay's former Executive Chairman. As Executive Chairman and Chief Business Development Officer, Mr. Zandman has a breadth of knowledge concerning the Company's businesses, as well as close familiarity with the Company's Israel operations where the Company conducts significant research and development and manufacturing activities.
|
|
|
Ruta Zandman is a private stockholder and the wife of the late Dr. Felix Zandman, Vishay's founder and former Executive Chairman. Mrs. Zandman has sole or shared voting power over approximately 42.9% of the Company's total voting power, for which it is deemed appropriate that she serve as a member of the Company's Board. Mrs. Zandman was employed by Vishay as a public relations associate from 1993 to May 2011, and usually accompanied Dr. Zandman as a representative of Vishay; she provides the Board with valuable insight into the Company and its history, as well as her understanding of Dr. Zandman's vision and the evolution of our operations. | |
|
Ziv Shoshani is Chief Executive Officer and President, and a member of the board of directors of Vishay Precision Group, Inc., an independent, publicly-traded company spun off from Vishay on July 6, 2010. Mr. Shoshani was Chief Operating Officer of Vishay from January 1, 2007 to November 1, 2009, and had been Executive Vice President of Vishay from 2000 until the date of the spin-off, with various areas of responsibility, including Executive Vice President of the Capacitors and the Resistors businesses, as well as heading the Measurements Group and Foil Divisions. Mr. Shoshani was employed by Vishay Intertechnology, Inc. from 1995 to 2010, and has been a member of the Vishay Intertechnology, Inc. Board of Directors since 2001. Mr. Shoshani's long-standing dedication to our Company, exemplified by his extensive management experience with Vishay Intertechnology prior to the VPG spin-off, as well as his experience as the CEO of a publicly-traded company, provide him with valuable insight into our business and operations, and makes him a valuable advisor to the Board. Mr. Shoshani is a nephew of Ruta Zandman. |
|
2019 Proxy Statement |
Director Compensation
|
|
|
•
|
An annualized cash retainer of $60,000, paid in two semi-annual installments;
|
|
•
|
An additional $10,000 for service on each of the Compensation or Audit Committees;
|
|
•
|
An additional $5,000 for service on the Nominating and Corporate Governance Committee;
|
| • | An additional $15,000 for the Audit Committee Chair and an additional $5,000 for each of the Compensation and Nominating and Corporate Governance Committee Chairs; and |
| • | An annual grant of RSUs on the first stock trading day of the year, determined as a total incentive value of $165,000 divided by the closing stock price of the last trading day of the previous fiscal year, vesting in 3 years or ratably upon earlier cessation of service. |
|
NAME
|
FEES EARNED AND PAID IN CASH
|
|
STOCK AWARDS
(
1
)
|
|
TOTAL
|
|
|||||
| Michael Cody (2) | $ | 5,753 | $ | - | $ | 5,753 | |||||
|
Dr. Abraham Ludomirski
|
$
|
80,000
|
|
$
|
163,573
|
|
$
|
243,573
|
|
||
|
Frank Dieter Maier
|
$
|
75,000
|
|
$
|
163,573
|
|
$
|
238,573
|
|
||
|
Ronald Ruzic
|
$
|
75,000
|
|
$
|
163,573
|
|
$
|
238,573
|
|
||
|
Ziv Shoshani
|
$
|
60,000
|
|
$
|
163,573
|
|
$
|
223,573
|
|
||
|
Timothy V. Talbert
|
$
|
75,000
|
|
$
|
163,573
|
|
$
|
238,573
|
|
||
|
Thomas C. Wertheimer
|
$
|
95,000
|
|
$
|
163,573
|
|
$
|
258,573
|
|
||
|
Ruta Zandman
|
$
|
210,000
|
(3) |
|
$
|
163,573
|
|
$
|
373,573
|
|
|
|
Raanan Zilberman
|
$
|
60,000
|
|
$
|
163,573
|
|
$
|
223,573
|
|
||
|
(1)
|
Amounts represent the fair value of the RSUs granted, determined in accordance with FASB ASC Topic 718 in the year of grant and the assumptions set forth in Note 12 of our consolidated financial statements on Form 10-K filed on February 15, 2019. The grant-date fair value is recognized for accounting purposes over the respective vesting periods.
|
|
(2)
|
Mr. Cody was appointed to the Board of Directors on November 27, 2018.
|
| (3) |
Effective January 1, 2012, Mrs. Ruta Zandman was appointed as the director responsible for preserving the memory of the late Dr. Felix Zandman and the Company's corporate history. For her continued service on this project, Mrs. Zandman receives $150,000 per annum in addition to her Board of Directors cash retainer of $60,000.
|
|
2019 Proxy Statement |
Director Stock Ownership Guidelines
|
|
|
•
|
Each non-employee director should own an amount of shares of Vishay Common Stock equal to 5 times the value of the director's annual cash retainer, subject to a 5-year phase-in period (i.e., through 2021, or later if elected after January 1, 2016);
|
|
•
|
Following the 5-year phase-in period, non-employee directors who do not meet the required ownership threshold would receive shares in place of the director's annual cash retainer and be subject to stock transfer restrictions until such time as the ownership threshold is satisfied;
|
|
•
|
For purposes of analyzing compliance with Stock Ownership Guidelines, only fully vested shares are included in a director's holdings (e.g. unvested RSUs are not included).
|
|
DIRECTOR
|
STATUS
|
|
|
| Michael Cody |
Compliant by end of the phase-in period
|
||
|
Dr. Abraham Ludomirski
|
Compliant
|
|
|
|
Frank Dieter Maier
|
Compliant
|
|
|
|
Ronald Ruzic
|
Compliant
|
|
|
|
Ziv Shoshani
|
Compliant
|
|
|
|
Timothy V. Talbert
|
Compliant
|
|
|
|
Thomas C. Wertheimer
|
Compliant
|
|
|
|
Ruta Zandman
|
Compliant
|
|
|
|
Raanan Zilberman
|
Compliant by end of the phase-in period
|
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
•
|
Review of Vishay's performance, strategies, and major decisions;
|
|
•
|
Oversight of Vishay's compliance with legal and regulatory requirements and the integrity of its financial statements;
|
|
•
|
Oversight of management, including review of the CEO's performance and succession planning for key management roles;
|
| • | Oversight of risk management; and |
| • | Oversight of compensation for the CEO, key executives and the Board, as well as oversight of compensation policies and programs for all employees. |
|
•
|
Corporate Governance Principles
|
|
•
|
Code of Business Conduct and Ethics
|
|
•
|
Code of Ethics Applicable to the Company's Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer or Controller and Financial Managers
|
| • | Audit Committee Charter |
| • | Nominating and Corporate Governance Committee Charter |
| • | Compensation Committee Charter |
| • | Nominating and Corporate Governance Committee Policy Regarding Qualification of Directors |
| • | Procedures for Securityholders' Submissions of Nominating Recommendations |
| • | Whistleblower and Ethics Hotline Procedures |
| • | Related Party Transactions Policy |
|
2019 Proxy Statement |
Governance of the Company
|
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
The Board of Directors maintains an Executive Committee, a Nominating and Corporate Governance Committee, an Audit Committee, and a Compensation Committee. Each Committee is described below. Copies of all Committee charters are available on our website and in print upon request. The composition of these Committees is summarized under "Directors" above.
|
|
|
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
Executive Committee
(1)
|
Audit Committee
|
Nominating and Corporate Governance Committee
|
Compensation Committee
|
|
Number of Meetings during 2018
|
-
|
8
|
6
|
4
|
|
(1)
|
The Executive Committee meets informally throughout the year to discuss various business issues. Informal meetings are not included in the number of meetings disclosed above.
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
The Audit Committee
reviews our policies and guidelines with respect to risk assessment and risk management, including our major financial risk exposures, and oversees the steps management has taken to monitor and control those exposures.
|
|
The Compensation Committee
considers risk issues when establishing and administering our compensation programs for executive officers and other key personnel.
|
|
The Nominating and Corporate Governance Committee
oversees corporate governance risks, including matters relating to the composition and organization of the Board and recommends to the Board how its effectiveness can be improved by changes in its composition and organization.
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
2019 Proxy Statement |
Governance of the Company
|
|
|
|
By Mail
|
|
|
By e-mail
|
||
|
Corporate Secretary
Vishay Intertechnology, Inc.
63 Lancaster Avenue
Malvern, PA 19355
|
|
boardofdirectors@Vishay.com
Communications should not exceed 1,000 words
|
|
2019 Proxy Statement |
Proposal One
|
|
| Class I nominees: | |
|
Dr. Gerald Paul
|
|
Timothy V. Talbert
|
|
Thomas C. Wertheimer
|
| Class II nominee: | |
|
Michael Cody |
|
The Board of Directors recommends that you vote "FOR ALL" the nominees
for election as Class I and Class II directors.
|
|
2019 Proxy Statement |
Report of the Audit Committee
|
|
|
2019 Proxy Statement |
Report of the Audit Committee
|
|
|
2019 Proxy Statement |
Proposal Two
|
|
|
|
2018
|
2017
|
|||||||
| Audit fees |
$
|
6,100,000
|
$
|
5,900,000
|
|||||
| Audit-related fees |
200,000
|
100,000
|
|||||||
| Tax fees |
800,000
|
700,000
|
|||||||
| All other fees |
100,000
|
200,000
|
|||||||
| Total fees |
$
|
7,200,000
|
$
|
6,900,000
|
|||||
|
The Audit Committee and the Board of Directors recommend that you vote "FOR"
the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2019. |
|
2019 Proxy Statement |
Security Ownership of Certain Beneficial Owners and Management
|
|
|
|
COMMON STOCK
|
CLASS B COMMON STOCK
|
|||||||||||||||||
|
NAME
|
SHARES OF STOCK
|
PERCENT OF CLASS
|
SHARES OF STOCK
|
PERCENT OF CLASS
|
VOTING POWER
|
||||||||||||||
|
Directors and Executive Officers
|
|||||||||||||||||||
|
Marc Zandman
|
-
|
|
*
|
8,618,334
|
(2)
|
71.2
|
%
|
34.0
|
%
|
||||||||||
| Michael Cody | - | * | - | - | * | ||||||||||||||
|
Werner Gebhardt
|
-
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Lori Lipcaman
|
33,477
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Dr. Abraham Ludomirski
|
76,047
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Frank Dieter Maier
|
47,100
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Dr. Gerald Paul
|
150,306
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Ronald Ruzic
|
86,970
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Ziv Shoshani
|
44,731
|
|
*
|
8,616,834
|
(3)
|
71.2
|
%
|
34.0
|
%
|
||||||||||
|
Joel Smejkal
|
-
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Timothy V. Talbert
|
32,923
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Clarence Tse
|
-
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
David Valletta
|
27,881
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Johan Vandoorn
|
25,881
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Thomas C. Wertheimer
|
37,370
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
Ruta Zandman
|
240,683
|
|
*
|
10,849,383
|
(1)
|
89.7
|
%
|
42.9
|
%
|
||||||||||
|
Raanan Zilberman
|
-
|
|
*
|
-
|
-
|
*
|
|||||||||||||
|
All Directors and Executive Officers as a group (17 Persons)
(4)
|
803,369 | * |
10,850,883
|
89.7
|
% | 43.2 | % | ||||||||||||
| Eugenia Ames (6) | - | * | 2,232,549 | 18.5 | % | * | (5) | ||||||||||||
| Deborah S. Larkin (7) | - | * | 706,755 | 5.8 | % | 2.8 | % | ||||||||||||
| BlackRock, Inc. (8) | 16,302,788 | 12.3 | % | - | - | 6.4 | % | ||||||||||||
| Dimensional Fund Advisors, LP (9) | 10,054,714 | 7.6 | % | - | - | 4.0 | % | ||||||||||||
| The Vanguard Group, Inc. (10) | 12,456,252 | 9.4 | % | - | - | 4.9 | % | ||||||||||||
| LSV Asset Management (11) | 7,129,261 | 5.4 | % | - | - | 2.8 | % | ||||||||||||
| DNB Asset Management AS (12) | 6,735,257 | 5.1 | % | - | - | 2.7 | % | ||||||||||||
| Schroder Investment Management Ltd (13) | 6,620,950 | 5.0 | % | - | - | 2.6 | % | ||||||||||||
|
2019 Proxy Statement |
Security Ownership of Certain Beneficial Owners and Management
|
|
|
(1)
|
Includes 8,616,834 shares of Class B common stock held in a family trust, of which Mrs. Ruta Zandman, Mr. Marc Zandman and Mr. Ziv Shoshani are co-trustees, and have shared voting power. Pursuant to an agreement related to that family trust, each of Mrs. Zandman and Messrs. Zandman and Shoshani is required to cause shares controlled by the trust to be voted in support of the election of each of the co-trustees as directors of the Company. Additionally, includes 2,232,549 shares of Class B common stock that are subject to a voting agreement pursuant to which Mrs. Zandman, as Voting Representative, may direct the voting of such shares.
|
|
(2)
|
Includes the same 8,616,834 shares of Class B common stock held in a family trust, of which Mrs. Ruta Zandman, Mr. Marc Zandman and Mr. Ziv Shoshani are co-trustees, and have shared voting power. Pursuant to an agreement related to that family trust, each of Mrs. Zandman and Messrs. Zandman and Shoshani is required to cause shares controlled by the trust to be voted in support of the election of each of the co-trustees as directors of the Company. Additionally, includes 750 shares of Class B common stock directly owned by Mr. Marc Zandman; and 750 shares of Class B common stock owned by one of Mr. Marc Zandman's children.
|
| (3) | Includes the same 8,616,834 shares of Class B common stock held in a family trust, of which Mrs. Ruta Zandman, Mr. Marc Zandman and Mr. Ziv Shoshani are co-trustees, and have shared voting power. Pursuant to an agreement related to that family trust, each of Mrs. Zandman and Messrs. Zandman and Shoshani is required to cause shares controlled by the trust to be voted in support of the election of each of the co-trustees as directors of the Company. |
| (4) |
The business address for all directors and officers is: c/o Vishay Intertechnology, Inc., 63 Lancaster Avenue, Malvern, PA 19355.
|
| (5) |
Such shares are subject to a voting agreement pursuant to which Mrs. Ruta Zandman, as Voting Representative, may direct the voting of such shares, and are included in the 2,232,549 shares of Class B common stock reported as being beneficially owned by Mrs. Zandman in Footnote 1. Ms. Ames has dispositive power of such shares. Ms. Ames is the record holder of 506,216 of these shares; the balance of the shares are held by trusts for the benefit of Ms. Ames's children and other family members.
|
| (6) | The business address for Eugenia Ames is Janney Montgomery Scott, 780 Route 37 West, Suite 130, Toms River, NJ 08755, c/o Mr. Leroy Rachlin. |
| (7) | The business address for Deborah S. Larkin is World Financial, 270 Madison Avenue, Suite 1503, New York, NY 10016, c/o Mr. Bruce Auerbach. |
| (8) |
Based on information provided in a Schedule 13G/A filed on February 11, 2019 by BlackRock, Inc. According to the Schedule 13G/A, BlackRock, Inc. may be deemed to have sole power to vote or direct the vote with respect to 15,815,345 shares of common stock; and sole power to dispose or direct the disposition with respect to 16,302,788 shares. BlackRock, Inc. is located at 55 East 52
nd
Street, New York, New York 10055.
|
| (9) |
Based on information provided in a Schedule 13G/A filed on February 8, 2019 by Dimensional Fund Advisors, LP. According to the Schedule 13G/A, Dimensional Fund Advisors, LP may be deemed to have sole power to vote or direct the vote with respect to 9,858,646 shares of common stock; and sole power to dispose or direct the disposition with respect to 10,054,714 shares. Dimensional Funds Advisors, LP is located at Palisades West, Building One, 6300 Bee Cave Road, Austin, Texas 78746.
|
| (10) |
Based on information provided in a Schedule 13G/A filed on February 11, 2019 by The Vanguard Group, Inc. According to the Schedule 13G/A, The Vanguard Group, Inc. may be deemed to have sole power to vote or direct the vote with respect to 133,336 shares of common stock; shared power to vote or direct the vote with respect to 17,013 shares of common stock; sole power to dispose or direct the disposition with respect to 12,321,197 shares; and shared power to dispose or direct the disposition with respect to 135,055 shares. The Vanguard Group, Inc. is located at 100 Vanguard Blvd., Malvern, PA 19355.
|
| (11) |
Based on information provided in a Schedule 13G filed on February 13, 2019 by LSV Asset Management. According to the Schedule 13G, LSV Asset Management may be deemed to have sole power to vote or direct the vote with respect to 4,680,602 shares of common stock; and sole power to dispose or direct the disposition with respect to 7,129,261 shares. LSV Asset Management is located at 155 N. Wacker Drive, Suite 4600, Chicago, IL 60606.
|
| (12) |
Based on information provided in a Schedule 13G filed on January 24, 2019 by DNB Asset Management AS. According to the Schedule 13G, DNB Asset Management AS may be deemed to have sole power to vote or direct the vote with respect to 6,735,257 shares of common stock; and sole power to dispose or direct the disposition with respect to 6,735,257 shares. DNB Asset Management AS is located at Dronning Aufemias Gate 30, Bygg M-12N, 0191 Oslo, Norway.
|
| (13) |
Based on information provided in a Schedule 13G filed on February 9, 2018 by Schroder Investment Management Ltd. Schroder Investment Management Ltd is located at 7 Bryant Park, 19
th
Floor, New York, New York 10018.
|
|
2019 Proxy Statement |
Security Ownership of Certain Beneficial Owners and Management
|
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
NAME
|
|
AGE
|
|
POSITION
|
|
|
|
|
|
|
|
Marc Zandman*
|
|
57
|
|
Executive Chairman of the Board, Chief Business Development Officer, President – Vishay Israel Ltd.
|
|
Dr. Gerald Paul*
|
|
70
|
|
Chief Executive Officer, President and Director
|
|
Lori Lipcaman
|
|
61
|
|
Executive Vice President and Chief Financial Officer
|
|
Johan Vandoorn
|
|
62
|
|
Executive Vice President and Chief Technical Officer
|
|
David Valletta
|
|
58
|
|
Executive Vice President – Worldwide Sales
|
| Clarence Tse | 60 | Executive Vice President Business Head Semiconductors | ||
| Joel Smejkal | 52 | Executive Vice President Business Head Passive Components | ||
| Werner Gebhardt | 60 | Executive Vice President Global Human Resources |
|
*
|
Biography is provided with the Directors' biographies under the heading "Directors".
|
|
Lori Lipcaman
was appointed Executive Vice President and Chief Financial Officer of the Company effective September 1, 2011. Ms. Lipcaman had been appointed Executive Vice President and Chief Accounting Officer in September 2008. Previously, she served as Vishay's Corporate Senior Vice President, Operations Controller, from March 1998 to September 2008. Prior to that, she served in various positions of increasing responsibility in finance and controlling since joining the Company in May 1989.
|
||
|
Johan Vandoorn was appointed Executive Vice President and Chief Technical Officer effective August 1, 2011. Mr. Vandoorn is responsible for Vishay's technical development and internal growth programs. Mr. Vandoorn has held various positions of increasing responsibility since Vishay's acquisition of BCcomponents Holdings BV ("BCcomponents") in 2002, including Executive Vice President – Passive Components (2006 – 2012). Mr. Vandoorn had been Vice President – Global Operations of BCcomponents from 2000 until its acquisition by Vishay, and previously worked for Philips Components ("Philips") from 1980 until Philips sold the BCcomponents business to a private equity firm in 1998. |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
David Valletta
was appointed as Vishay's Executive Vice President – Worldwide Sales effective January 1, 2007. Mr. Valletta has held various positions of increasing responsibility since Vishay's acquisition of Vitramon in 1994. Prior to joining Vitramon, Mr. Valletta also worked for AVX Corporation. His experience with Vishay includes various positions within the Americas region in direct and distribution sales management and global sales responsibility for the Company's key strategic customers.
|
||
|
Clarence Tse was appointed Executive Vice President and Business Head Semiconductors effective January 1, 2017. Mr. Tse has held various positions of increasing responsibility since Vishay's acquisition of Siliconix/Telefunken in 1998, including Senior Vice President, Diodes Division (2008 - 2016), Senior Vice President, Power Diodes Division (2002 - 2008) and Vice President, Finance and Administration Asia (1998 - 2001). Mr. Tse was first hired by Siliconix in 1985. | ||
|
Joel Smejkal
was appointed Executive Vice President and Business Head Passive Components effective January 1, 2017. Mr. Smejkal has held various positions of increasing responsibility since joining Vishay in 1990 including Senior Vice President Global Distribution Sales (2012 - 2016). Mr. Smejkal's experience with Vishay includes worldwide and divisional leadership roles in engineering, marketing, operations and sales. He was a product developer of 18 U.S. Patents for the Power Metal Strip® resistor technology and brings significant business development, marketing and sales experience.
|
||
|
Werner Gebhardt was appointed Executive Vice President Global Human Resources effective January 1, 2017. Mr. Gebhardt has held various positions of increasing responsibility since Vishay's acquisition of Draloric Electronic GmbH ("Draloric") in 1987, including Senior Vice President Global Human Resources (2011 - 2014) and Administrative President Europe (2006 - 2011). Mr. Gebhardt's experience with Vishay includes leadership roles in Administration and Human Resources. Mr. Gebhardt had been employed by Draloric since 1975. |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
•
|
Minimum base salary levels are fixed in amount;
|
|
•
|
While annual cash bonuses focus on the achievement of short-term or annual goals and short-term goals may encourage risk-taking, annual cash bonuses for Executive Officers are capped in order to balance the risk; and
|
|
•
|
A significant portion of our RSUs carry both service and performance conditions which are tied to operating results over a three-year period. |
|
•
|
a meaningful portion of compensation is deferred until retirement or termination of employment under our non-qualified deferred compensation plan; and
|
|
•
|
phantom stock units are only settled upon retirement or termination of employment, thus providing an incentive for the creation of long-term stockholder value.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
•
|
Advanced Micro Devices
|
•
|
Microchip Technology |
|
•
|
Analog Devices
|
•
|
Microsemi Corporation |
|
•
|
AVX Corp. |
•
|
ON Semiconductor Corp. |
|
•
|
Cree, Inc. |
•
|
Skyworks Solutions, Inc. |
|
•
|
Cypress Semiconductor |
•
|
Xilinx, Inc. |
|
•
|
Maxim Integrated Products |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
|
YEARS ENDED DECEMBER 31,
|
|||||||||||
|
|
2018
|
2017
|
2016
|
|||||||||
|
|
||||||||||||
|
GAAP net earnings (loss) attributable to Vishay stockholders
|
$
|
345,758
|
$
|
(20,344
|
)
|
$
|
48,792
|
|||||
|
|
||||||||||||
|
Reconciling items affecting operating income:
|
||||||||||||
|
Restructuring and severance costs
|
$
|
-
|
$
|
11,273
|
$
|
19,199
|
||||||
|
Impairment of intangible assets
|
-
|
-
|
1,559
|
|||||||||
|
|
||||||||||||
|
Reconciling items affecting other income (expense):
|
||||||||||||
|
Loss (gain) on early extinguishment of debt
|
$
|
26,583 | $ | - | $ |
(4,597
|
) | |||||
|
Loss on disposal of equity affiliate
|
|
-
|
|
|
6,112
|
|
-
|
|||||
| U.S. pension settlement charges | - | - | 79,321 | |||||||||
|
Gain related to Tianjin explosion
|
-
|
|
-
|
(8,809
|
) | |||||||
|
|
||||||||||||
|
Reconciling items affecting tax expense (benefit):
|
||||||||||||
| Enactment of TCJA | $ | 25,496 | $ | 234,855 | $ | - | ||||||
|
Effects of cash repatriation program
|
|
(10,047
|
)
|
|
(5,802
|
) |
|
(3,553
|
) | |||
|
Changes in deferred taxes due to early extinguishment of debt
|
(54,877
|
) |
-
|
-
|
||||||||
|
Additional tax expense from AOCI - pension plans
|
-
|
-
|
|
34,853
|
||||||||
|
Effects of changes in uncertain tax positions
|
-
|
|
1,565
|
|
(8,704
|
)
|
||||||
|
Tax effects of pre-tax items above
|
(5,812
|
)
|
(3,331
|
)
|
(29,901
|
)
|
||||||
|
|
||||||||||||
|
Adjusted net earnings
|
$
|
327,101
|
$
|
224,328
|
$
|
128,160
|
||||||
|
|
||||||||||||
|
Adjusted weighted average diluted shares outstanding
|
154,622
|
157,010
|
150,697
|
|||||||||
|
|
||||||||||||
|
Adjusted earnings per diluted share *
|
$
|
2.12
|
$
|
1.43
|
$
|
0.85
|
||||||
|
|
||||||||||||
|
* Includes add-back of interest on exchangeable notes in periods where the notes are dilutive.
|
||||||||||||
|
2019 Proxy Statement |
Executive Compensation
|
|
|
|
YEARS ENDED DECEMBER 31,
|
|||||||||||
|
|
2018
|
2017
|
2016
|
|||||||||
|
Net cash provided by continuing operating activities
|
$
|
258,506
|
$
|
368,777
|
$
|
296,509
|
||||||
|
Proceeds from sale of property and equipment
|
55,561
|
1,685
|
5,701
|
|||||||||
|
Less: Capital expenditures
|
(229,899
|
)
|
(170,432
|
)
|
(134,635
|
)
|
||||||
|
Free cash
|
$
|
84,168 |
$
|
200,030
|
$
|
167,575
|
||||||
|
•
|
adjusted net earnings;
|
|
•
|
third party net sales;
|
|
•
|
variable margin;
|
|
•
|
gross profit margin;
|
|
•
|
free cash;
|
|
•
|
segment operating income; and |
|
•
|
divisional cash flow. |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
SHORT TERM
|
|
MEDIUM TERM
|
|
LONG TERM
|
|||
|
•
|
Base salary
|
|
•
|
Equity-based compensation
|
|
•
|
Retirement benefits
|
|
•
|
Cash performance-based incentive compensation
|
|
|
|
|
•
|
Contributions to the Company's deferred compensation plan*
|
|
•
|
Perquisites and other personal benefits
|
|
|
|
|
|
|
| * | For Dr. Paul, Mr. Zandman, and Mr. Valletta | ||||||
|
NAME
|
2018 BASE SALARY
|
|
|
Marc Zandman
|
ILS 3,604,764 (approximately $1,003,000)
(1)
|
|
|
Dr. Gerald Paul
|
€999,485(approximately $1,180,000)
(2)
|
|
|
Lori Lipcaman
|
€418,462 (approximately $494,000)
(2)
|
|
|
Johan Vandoorn
|
€469,970 (approximately $555,000)
(2)
|
|
|
David Valletta
|
$512,419
|
|
| Clarence Tse | TWD 17,616,230 (approximately $584,000) (3) | |
| Joel Smejkal | $335,107 | |
| Werner Gebhardt | €242,742 (approximately $287,000) (2) |
|
(1)
|
Paid in Israeli shekels.
|
|
(2)
|
Paid in euro.
|
|
(3)
|
Paid in Taiwan dollars.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
NAME
|
PERCENTAGE OF ADJUSTED NET EARNINGS |
DOLLAR VALUE ($)
|
|||
|
Marc Zandman
|
1.00% |
3,271,010
|
(1) | ||
|
Dr. Gerald Paul
|
1.25% |
4,088,763
|
(1) | ||
| Lori Lipcaman | 0.10% | 327,101 | |||
|
Johan Vandoorn
|
0.10% |
327,101
|
(1) | ||
|
David Valletta
|
0.05% |
163,551
|
|||
|
Clarence Tse
|
0.07% |
228,971
|
|||
|
Joel Smejkal
|
0.07% |
228,971
|
(1) | ||
|
Werner Gebhardt
|
0.05% |
163,551
|
|||
| (1) Amount paid limited by the cap set by the Compensation Committee | |||||
|
2019 Proxy Statement |
Executive Compensation
|
|
|
NAME
|
|
LTI VALUE
|
|
Marc Zandman
|
|
125% of base salary
|
|
Dr. Gerald Paul
|
|
150% of base salary
|
|
Lori Lipcaman
|
|
40% of base salary
|
|
Johan Vandoorn
|
|
40% of base salary
|
|
David Valletta
|
|
40% of base salary
|
| Clarence Tse | 30% of base salary | |
| Joel Smejkal |
30% of base salary
|
|
| Werner Gebhardt |
30% of base salary
|
|
NAME
|
|
TIME-VESTED
RSUs
|
|
|
PBRSUs
|
|
|
TOTAL
|
|
|||
|
Marc Zandman
|
|
|
15,064
|
|
|
|
45,191
|
|
|
|
60,255 |
|
|
Dr. Gerald Paul
|
|
|
20,334
|
|
|
|
61,003
|
|
|
|
81,337 |
|
|
Lori Lipcaman
|
|
|
2,270
|
|
|
|
6,811
|
|
|
|
9,081 |
|
|
Johan Vandoorn
|
|
|
2,550
|
|
|
|
7,649
|
|
|
|
10,199 |
|
|
David Valletta
|
|
|
2,469
|
|
|
|
7,409
|
|
|
|
9,878 |
|
| Clarence Tse | 2,090 | 6,271 | 8,361 | |||||||||
| Joel Smejkal | 1,211 | 3,634 | 4,845 | |||||||||
| Werner Gebhardt | 988 | 2,963 | 3,951 | |||||||||
|
2019 Proxy Statement |
Executive Compensation
|
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Free cash
(2)
|
|
12.5%
|
|
12.5%
|
|
>100%
|
|
12.5%
|
|
Fixed costs
(2)
|
|
7.5%
|
|
7.5%
|
|
>100%
|
|
7.5%
|
|
Personal objectives
(3)
|
|
10.0%
|
|
10.0%
|
|
92%
|
|
9.2%
|
|
Total
|
|
30.0%
|
|
30.0%
|
|
|
|
29.2%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Ms. Lipcaman's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: implementing changes required by the US Tax Cuts and Jobs Act (3.0%); developing a strategy to refinance certain debt instruments (3.0%); overseeing the implementation of the General Data Protection Regulation (1.0%); developing a roadmap for certain finance-related IT projects (1.0%); and serving as executive sponsor of a finance-related IT project (2.0%). The achievement of these goals was evaluated and measured in the aggregate.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Variable margin of defined R&D projects
(4)
|
|
15.0%
|
|
15.0%
|
|
90%
|
|
13.5%
|
|
Third party net sales of defined R&D projects
(4)
|
|
10.0%
|
|
10.0%
|
|
89%
|
|
8.9%
|
| Free cash (2) | 10.0% | 10.0% | >100% | 10.0% | ||||
| Fixed costs (2) | 5.0% | 5.0% | >100% | 5.0% | ||||
|
Personal objectives
(3)
|
|
10.0%
|
|
10.0%
|
|
95%
|
|
9.5%
|
|
Total
|
|
50.0%
|
|
50.0%
|
|
|
|
46.9%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Mr. Vandoorn's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: meeting R&D milestones (2.0%); defining new innovation targets to achieve sales target (1.5%); fostering acquisition plans (1.5%); completing certain strategic projects (4.0%); and supporting investor relations, including participation in investor conferences (1.0%). The achievement of these goals was evaluated and measured in the aggregate.
|
| (4) | Partial achievement recognized ratably. |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Third party net sales
(4)
|
|
5.0%
|
|
15.0%
|
|
114%
|
|
12.0%
|
|
Standard variable margin on actual sales
(2)(5)
|
|
12.5%
|
|
12.5%
|
|
>100%
|
|
12.5%
|
| Free cash (2) | 10.0% | 10.0% | >100% | 10.0% | ||||
| Fixed costs (2) | 5.0% | 5.0% | >100% | 5.0% | ||||
|
Personal objectives
(3)
|
|
7.5%
|
|
7.5%
|
|
84%
|
|
6.3%
|
|
Total
|
|
40.0%
|
|
50.0%
|
|
|
|
45.8%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Mr. Valletta's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: supporting the growth plan, particularly in Asia, including specific performance metrics (2.0%); improving the efficiency of the sales force and implementing an improvement plan (1.5%); defining an improved sales budget variance analysis program (1.0%); developing new incentive programs for the sales force (1.0%); achieving accounts receivable aging targets (1.0%); and maintaining consignment inventories at specific inventory turnover targets (1.0%). The achievement of these goals was evaluated and measured in the aggregate.
|
| (4) | Mr. Valletta would not be eligible to receive a bonus if actual performance were less than 90% of budget. If actual third party net sales were between 90% and 100% of budget, applicable bonus increases ratably from 0% to 5% of base salary. If actual third party net sales were between 100% and 120% of budget, applicable bonus increases ratably from 5% to 15% of base salary. |
| (5) | The use of standard variable margin based on actual sales (rather than actual variable margin) allows Mr. Valletta's profitability achievement to be measured independent of production efficiencies/inefficiencies over which he has no control. |
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Adjusted operating margin, Semiconductor segments
(4)
|
|
9.0%
|
|
15.0%
|
|
123%
|
|
13.6%
|
|
Divisional free cash - Semiconductor segments
(2)
|
|
7.0%
|
|
7.0%
|
|
>100%
|
|
7.0%
|
| Variable margin of defined R&D projects (2) | 5.0% | 5.0% |
>100%
|
5.0%
|
||||
| Variable margin on Semiconductor segments' sales (2) | 5.0% | 5.0% |
>100%
|
5.0%
|
||||
| Defined goals for organic growth - Semiconductor segments (2) | 8.0% | 8.0% |
96%
|
7.7% | ||||
|
Personal objectives
(3)
|
|
10.0%
|
|
10.0%
|
|
90%
|
|
9.0%
|
|
Total
|
|
44.0%
|
|
50.0%
|
|
|
|
47.3%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Mr. Tse's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: achieving quality targets and implementing certain improvement programs (3.0%); achieving service targets (1.5%); achieve certain pricing targets (2.0%); and completing strategic operations projects, including identifying certain long-term supply chain partners and moving certain production (3.5%). The achievement of these goals was evaluated and measured in the aggregate.
|
| (4) |
Mr. Tse would not be eligible to receive a bonus if actual performance were less than 85% of budget. If actual adjusted operating margins were between 85% and 100% of budget, applicable bonus increases ratably from 0% to 9% of base salary. If adjusted operating margins were between 100% and 130% of budget, applicable bonus increases ratably from 9% to 15% of base salary.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Adjusted operating margin, Passive Components segments
(4)
|
|
9.0%
|
|
15.0%
|
|
>130%
|
|
15.0%
|
|
Divisional free cash - Passive Components segments
(2)
|
|
7.0%
|
|
7.0%
|
|
>100%
|
|
7.0%
|
| Variable margin of defined R&D projects (2) | 5.0% | 5.0% |
75%
|
3.75%
|
||||
| Variable margin on Passive Components segments' sales (2) | 5.0% | 5.0% |
>100%
|
5.0%
|
||||
| Defined goals for organic growth - Passive Components segments (2) | 8.0% | 8.0% |
90%
|
7.2% | ||||
|
Personal objectives
(3)
|
|
10.0%
|
|
10.0%
|
|
86.5%
|
|
8.65%
|
|
Total
|
|
44.0%
|
|
50.0%
|
|
|
|
46.6%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Mr. Smejkal's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: exceeding certain sales targets (2.0%); meeting capital spending targets (1.0%); achieving service targets (1.0%); achieving quality targets (1.0%); re-defining the strategic direction of certain product lines (1.0%); achieving certain growth targets for specific product lines (2.0%); and completing strategic operations projects, including aligning manufacturing capacity and moving certain production (2.0%). The achievement of these goals was evaluated and measured in the aggregate.
|
| (4) |
Mr. Smejkal would not be eligible to receive a bonus if actual performance were less than 85% of budget. If actual adjusted operating margins were between 85% and 100% of budget, applicable bonus increases ratably from 0% to 9% of base salary. If adjusted operating margins were between 100% and 130% of budget, applicable bonus increases ratably from 9% to 15% of base salary.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
CATEGORY
|
|
TARGET
(1)
|
|
MAXIMUM
|
|
RELATIVE ACHIEVEMENT VS. BUDGET/EXPECTATION
|
|
ACHIEVEMENT (AS A PERCENTAGE OF BASE SALARY)
|
|
Free cash
(2)
|
|
10.0%
|
|
10.0%
|
|
>100%
|
|
10.0%
|
|
Fixed costs
(2)
|
|
10.0%
|
|
10.0%
|
|
90%
|
|
9.0%
|
|
Personal objectives
(3)
|
|
10.0%
|
|
10.0%
|
|
75%
|
|
7.5%
|
|
Total
|
|
30.0%
|
|
30.0%
|
|
|
|
26.5%
|
|
(1)
|
The percentage at "Target" in this table represents the bonus payable at achievement of 100% of budget / expectation.
|
|
(2)
|
To the extent actual was less than the budget, the determination of an appropriate partial bonus percentage would be made by the Compensation Committee in consultation with the CEO.
|
|
(3)
|
Mr. Gebhardt's individual performance goals for 2018 (with related bonus opportunity as a percentage of base salary in parentheses) included: enhancing HR's role as a business partner with operations (4.0%); harmonizing regional HR practices for worldwide standardization (3.5%); administering an employee development program (2.0%); and coordination of certain HR activities with IT (0.5%). The achievement of these goals was evaluated and measured in the aggregate.
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
•
|
advanced training fund, 7.5% of base salary
|
|
•
|
severance fund, 8.33% of base salary
|
|
•
|
disability insurance, 2.5% of base salary
|
|
•
|
pension fund, 5% of base salary
|
|
2019 Proxy Statement |
Executive Compensation
|
|
|
2019 Proxy Statement |
Report of the Compensation Committee
|
|
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
|
|
SALARY
|
BONUS
|
STOCK AWARDS
|
|
NON-EQUITY INCENTIVE PLAN COMP.
|
|
CHANGE IN PENSION VALUE AND NON-QUALIFIED DEFERRED COMP. EARNINGS
|
|
ALL OTHER COMP.
|
|
|
|
||||||||||
|
|
|
|
(1)
|
(2) |
(3)(4)(5)
|
|
(6)
|
|
(7)(8)(9)
|
|
(10)
|
|
TOTAL
|
|
||||||||||
|
NAME AND PRINCPAL POSITION
|
|
YEAR
|
|
($)
|
($) |
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
|||||||||
|
(a)
|
|
(b)
|
|
(c)
|
(d) |
(e)
|
|
(g)
|
|
(h)
|
|
(i)
|
|
(j)
|
|
|||||||||
|
Marc Zandman
|
|
2018
|
|
$
|
1,003,442
|
$ |
-
|
$
|
1,211,224
|
|
$
|
3,010,325
|
|
$
|
45,799
|
|
$
|
506,391
|
|
$
|
5,777,181
|
|
||
|
Executive Chairman of the Board,
|
|
2017
|
|
|
961,769
|
-
|
|
1,162,265
|
|
|
2,243,280
|
|
|
933,944
|
|
|
480,333
|
|
|
5,781,591
|
|
|||
|
Chief Business Development Officer,
|
|
2016
|
|
|
876,414
|
-
|
|
1,086,240
|
|
|
1,281,600
|
|
|
524,275
|
|
|
426,167
|
|
|
4,194,696
|
|
|||
|
and President - Vishay Israel Ltd.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Dr. Gerald Paul
|
|
2018
|
|
|
1,180,448
|
-
|
|
1,597,657
|
|
|
3,541,342
|
|
|
340,855
|
|
|
445,810
|
|
|
7,106,112
|
|
|||
|
President and Chief Executive Officer
|
|
2017
|
|
|
1,081,890
|
-
|
|
1,609,815
|
|
|
2,804,100
|
|
|
647,689
|
|
|
191,553
|
|
|
6,335,047
|
|
|||
|
|
|
2016
|
|
|
1,032,707
|
221,370
|
|
1,531,965
|
|
|
1,602,000
|
|
|
163,096
|
|
|
189,249
|
|
|
4,740,387
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Lori Lipcaman
|
|
2018
|
|
|
494,227
|
-
|
|
166,455
|
|
|
471,415
|
|
|
154,613
|
|
|
28,568
|
|
|
1,315,278
|
|
|||
|
Executive Vice President and
|
|
2017
|
|
|
452,963
|
-
|
|
170,658
|
|
|
357,997
|
|
|
297,239
|
|
|
27,069
|
|
|
1,305,926
|
|
|||
|
Chief Financial Officer
|
|
2016
|
|
|
432,371
|
-
|
|
164,507
|
|
|
255,709
|
|
|
167,008
|
|
|
26,320
|
|
|
1,045,915
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Johan Vandoorn
|
|
2018
|
|
|
555,061
|
-
|
|
186,948
|
|
|
555,061
|
|
|
-
|
|
|
152,017
|
|
|
1,449,087
|
|
|||
|
Executive Vice President and
|
|
2017
|
|
|
508,718
|
-
|
|
191,672
|
|
|
457,349
|
|
|
-
|
|
|
135,561
|
|
|
1,293,300
|
|
|||
|
Chief Technical Officer
|
|
2016
|
|
|
454,690
|
-
|
|
172,996
|
|
|
249,593
|
|
|
-
|
|
|
201,732
|
|
|
1,079,011
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Clarence Tse
(11)
|
2018
|
584,278
|
-
|
153,257
|
505,334
|
15,829
|
136,593
|
1,395,291
|
||||||||||||||||
|
Executive Vice President
|
2017
|
556,043 | - | 146,214 | 412,308 | - | 117,248 | 1,231,813 | ||||||||||||||||
|
Business Head Semiconductors
|
||||||||||||||||||||||||
|
2019 Proxy Statement |
Compensation Tables
|
|
|
(1)
|
Column (c) reflects base salary earned during the respective years. The employment agreements for Dr. Paul, Mr. Vandoorn, and Ms. Lipcaman specify that their salaries be denominated and paid in euro. The employment agreement for Mr. Zandman provides for his salary to be denominated and paid in Israeli shekels. The employment agreement for Mr. Tse specifies for his salary to be denominated and paid in new Taiwan dollars. The amounts presented have been converted into U.S. dollars at the weighted average exchange rate for the year.
|
|
(2)
|
Column (d) reflects bonuses earned by our Named Executive Officers during the respective years. The 2016 amount in column (d) for Dr. Paul is representative of a special transaction bonus granted upon the successful completion of the MOSFETs Enhanced Competitiveness Program.
|
|
(3)
|
Column (e) represents the grant-date fair value of RSUs and PBRSUs granted in the respective years determined in accordance with FASB ASC Topic 718 in the year of grant and the assumptions set forth in Note 12 of our consolidated financial statements included in our Form 10-K filed on February 15, 2019. The grant-date fair value is recognized for accounting purposes over the period the recipient is required to provide service in exchange for the respective awards. At the grant date, the Company expected all performance-based vesting criteria to be achieved. Accordingly, Column (e) includes the grant-date fair value for the PBRSUs. The common stock underlying the RSU and PBRSU awards is not received until the awards are vested (in some cases, subject to satisfaction of performance conditions) and accordingly, there can be no assurance that the grant-date fair value of these awards will ever be realized.
|
| (4) | The performance-based criteria for the 2016 PBRSU awards were met. |
| (5) | Column (e) also includes the grant-date fair value of 5,000 phantom stock units awarded annually to certain Named Executive Officers pursuant to the terms of their employment agreements. The common stock underlying these awards is not received until termination of employment, and accordingly, there can be no assurance that the grant-date fair value of these awards will ever be realized. |
| (6) | Column (g) reflects non-equity incentive compensation earned by our executive officers during the respective years, translated at the weighted average exchange rate for the year. The incentive compensation for Dr. Paul and Messrs. Zandman and Vandoorn was limited by the caps set by the Compensation Committee and included in their respective employment agreements. |
| (7) | Column (h) reflects the change in the actuarial present value of the Named Executive Officer's pension and other post employment benefits under respective defined benefit retirement plans, from the plan measurement date used in preparing the prior year consolidated financial statements to the plan measurement date used in preparing the current year consolidated financial statements, determined using the same interest rate, mortality, and other actuarial assumptions used in our consolidated financial statements as set forth in Note 11 thereof. Mr. Vandoorn does not participate in any defined benefit retirement plans. |
| (8) | The Company includes in these pension and post employment benefits certain termination benefits for Dr. Paul and Mr. Zandman which are payable at normal retirement if such executives are employed by the Company at age 62. See "Pension and Retirement Benefits" beginning on page 50. |
| (9) | Dr. Paul and Mr. Zandman also receive annual contributions to our non-qualified deferred compensation plan under which amounts deferred are credited with earnings based on the performance of notional investment options available under the plan. No portion of the earnings credited during 2018, 2017, or 2016 was "above market" or "preferential." Consequently, no deferred compensation plan earnings are included in the amounts reported in column (h). See the "Non-qualified Deferred Compensation" table for more information on the benefits payable under the non-qualified deferred compensation plan. |
|
2019 Proxy Statement |
Compensation Tables
|
|
| (10) | All other compensation includes amounts deposited on behalf of each Named Executive Officer into Vishay's non-qualified deferred compensation plan pursuant to the employment agreements with each Executive Officer, Jubilee service awards, personal use of company car, Company contributions to defined contribution plans outside of the United States, benefits generally available to employees in Israel, medical benefits in excess of normal group or government health insurance in country of residence, additional units of phantom stock granted as a result of dividends declared by the Company, and other perquisites, as described below (asterisk denotes amounts paid in foreign currency and translated at average exchange rates for the year): |
|
|
2018
|
2017
|
2016
|
|
|||||||||
|
Marc Zandman
|
$
|
100,000
|
$
|
100,000
|
$
|
100,000
|
Company contribution to non-qualified deferred compensation plan
|
||||||
|
|
45,550
|
45,880
|
45,662
|
Personal use of Company car*
|
|||||||||
|
|
260,946
|
243,893
|
206,055
|
Israeli employment benefits*
|
|||||||||
|
|
72,838
|
70,738
|
56,269
|
Medical and prescription drug insurance premiums (Blue Cross / Blue Shield)
|
|||||||||
|
|
27,057
|
19,822
|
18,181
|
Phantom stock - dividend equivalents
|
|||||||||
|
|
$
|
506,391
|
$
|
480,333
|
$
|
426,167
|
Total
|
||||||
|
|
|
||||||||||||
|
Dr. Gerald Paul
|
$
|
$100,000
|
$
|
100,000
|
$
|
100,000
|
Company contribution to non-qualified deferred compensation plan
|
||||||
|
|
44,788
|
42,553
|
41,745
|
Personal use of Company car*
|
|||||||||
|
|
28,035
|
29,178
|
29,323
|
Company-paid medical costs*
|
|||||||||
| 245,930 | - | - | Jubilee service award* | ||||||||||
|
|
27,057
|
19,822
|
18,181
|
Phantom stock - dividend equivalents
|
|||||||||
|
|
$
|
445,810
|
$
|
191,553
|
$
|
189,249
|
Total
|
||||||
|
|
|
||||||||||||
|
Lori Lipcaman
|
$
|
14,988
|
$
|
14,285
|
$
|
14,046
|
Personal use of Company car*
|
||||||
|
|
13,580
|
12,784
|
12,274
|
Company-paid medical costs*
|
|||||||||
|
|
$
|
28,568
|
$
|
27,069
|
$
|
26,320
|
Total
|
||||||
|
|
|
||||||||||||
|
Johan Vandoorn
|
$
|
4,694
|
$
|
4,781
|
$
|
4,857
|
Personal use of Company car*
|
||||||
|
|
142,867
|
126,541
|
192,712
|
Contribution to defined contribution retirement plan and related life insurance*
|
|||||||||
|
|
204
|
186
|
178
|
Company-paid medical costs*
|
|||||||||
|
|
4,252
|
4,053
|
3,985
|
Allowances*
|
|||||||||
|
|
$
|
152,017
|
$
|
135,561
|
$
|
201,732
|
Total
|
||||||
|
|
|
||||||||||||
| Clarence Tse | $ |
61,319
|
$ | 49,853 |
Personal use of Company car*
|
||||||||
|
38,323
|
39,042 |
Contribution to defined contribution retirement plan and related life insurance*
|
|||||||||||
|
6,870
|
4,643 |
Company-paid medical costs*
|
|||||||||||
|
10,298
|
14,450 | Children tuition subsidy* | |||||||||||
|
9,618
|
9,260 | Travel expenses* | |||||||||||
| 10,165 | - | Accounting services* | |||||||||||
| $ |
136,593
|
$ | 117,248 | Total | |||||||||
| (11) | Mr. Tse was appointed an Executive Officer effective January 1, 2017. |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
|
|
|
ESTIMATED FUTURE PAYOUTS UNDER NON-EQUITY INCENTIVE PLAN AWARDS
|
EQUITY INCENTIVE PLAN AWARDS: NUMBER OF SHARES OF STOCK OR UNITS
|
ALL OTHER STOCK AWARDS: NUMBER OF SHARES OF STOCK OR UNITS
|
|
GRANT DATE FAIR VALUE OF STOCK AWARDS
|
|||||||||||
|
|
|
|
|
(1)
|
(2)
|
(3)
|
|
(4)
|
|||||||||||
|
|
|
GRANT
|
|
THRESHOLD
|
TARGET
|
|
MAXIMUM
|
THRESHOLD
|
TARGET
|
|
MAXIMUM
|
|
|
|
|
||||
|
NAME
|
|
DATE
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
($)
|
|
|
Marc Zandman
|
1/1/2018
|
|
-
|
|
2,100,000
|
|
3,010,325
|
|
-
|
|
-
|
|
-
|
|
5,000
|
|
|
106,750
|
|
|
|
|
3/6/2018
|
|
-
|
|
-
|
|
-
|
|
22,596
|
|
45,191
|
|
45,191
|
|
15,064
|
|
1,104,474
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Gerald Paul
|
1/1/2018
|
|
-
|
|
2,625,000
|
|
3,541,342
|
|
-
|
|
-
|
|
-
|
|
5,000
|
|
|
106,750
|
|
|
|
|
3/6/2018
|
|
-
|
|
-
|
|
-
|
|
30,502
|
|
61,003
|
|
61,003
|
|
20,334
|
|
|
1,490,907
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lori Lipcaman
|
1/1/2018
|
|
-
|
|
358,268
|
|
494,227
|
|
-
|
|
-
|
|
-
|
|
-
|
|
|
-
|
|
|
|
|
3/6/2018
|
|
-
|
|
-
|
|
-
|
|
3,406
|
|
6,811
|
|
6,811
|
|
2,270
|
|
|
166,455
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Johan Vandoorn
|
1/1/2018
|
|
-
|
|
487,530
|
|
555,061
|
|
-
|
|
-
|
|
-
|
|
-
|
|
|
-
|
|
|
|
|
3/6/2018
|
|
-
|
|
-
|
|
-
|
|
3,825
|
|
7,649
|
|
7,649
|
|
2,550
|
|
|
186,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clarence Tse | 1/1/2018 | - |
404,083
|
584,278
|
- | - | - | - | - | ||||||||||
| 3/6/2018 | - | - | - |
3,362
|
6,721
|
6,271
|
2,090
|
153,257
|
|||||||||||
|
(1)
|
Amounts in these columns represent the threshold, target and maximum bonus levels for each Named Executive Officer. | ||
| (2) | Included in this columns are PBRSUs granted pursuant to the respective employment agreements of the Named Executive Officers. The number of RSUs shown in the "threshold" column are those that would vest if 80% of the applicable performance criteria are achieved. | ||
| (3) |
Included in this column are awards of phantom stock granted to Dr. Paul and Mr. Zandman and annual awards of RSUs granted pursuant to the respective employment agreements of the Named Executive Officers.
|
||
| (4) | Amounts in this column include: | ||
|
•
|
the grant-date fair value of the RSUs. The amount is calculated using the closing price of Vishay stock on the date of grant of $19.10 adjusted for the present value of expected dividends. The common stock underlying these awards is not received until the awards are vested (in some cases, subject to the satisfaction of performance conditions) and accordingly, there can be no assurance that the grant-date fair value of these awards will ever be realized.
|
|
•
|
the grant-date fair value of 5,000 phantom stock units awarded annually to certain executive officers pursuant to the terms of their employment agreements. The amount is calculated using the closing price of Vishay stock on the grant date of $21.35. The common stock underlying these awards is not received until termination of employment, and accordingly, there can be no assurance that the grant-date fair value of these awards will ever be realized.
|
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
|
|
|
STOCK AWARDS
|
||||||
|
NAME
|
|
GRANT DATE
(1)(2)
|
|
NUMBER OF SHARES OR UNITS OF STOCK THAT HAVE NOT VESTED
(#)
|
|
MARKET VALUE OF SHARES OF UNITS OF STOCK THAT HAVE NOT VESTED
($)
(3)
|
|
EQUITY INCENTIVE PLAN AWARDS: NUMBER OF UNEARNED SHARES, UNITS OR OTHER RIGHTS THAT HAVE NOT VESTED
(#)
|
|
EQUITY INCENTIVE PLAN AWARDS: MARKET OR PAYOUT VALUE OF UNEARNED SHARES, UNITS OR OTHER RIGHTS THAT HAVE NOT VESTED
($)
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marc Zandman
|
|
3/1/2016
|
|
22,458
|
|
404,469
|
|
67,375
|
|
1,213,424
|
|
|
|
2/23/2017
|
|
17,413 |
|
313,608
|
|
52,240
|
|
940,842
|
| 3/6/2018 | 15,064 | 271,303 | 45,191 | 813,890 | ||||||
|
Total
|
|
|
|
54,935
|
|
989,380
|
|
164,806
|
|
2,968,156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Gerald Paul
|
|
3/1/2016
|
|
32,199
|
|
579,904
|
|
96,596
|
|
1,739,694
|
|
|
|
2/23/2017
|
|
24,622
|
|
443,442
|
|
73,868
|
|
1,330,363
|
| 3/6/2018 | 20,334 | 366,215 | 61,003 | 1,098,664 | ||||||
|
Total
|
|
|
|
77,155
|
|
1,389,561
|
|
231,467
|
|
4,168,721
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lori Lipcaman
|
|
3/1/2016
|
|
3,595
|
|
64,746
|
|
10,785
|
|
194,238
|
|
|
|
2/23/2017
|
|
2,749
|
|
49,509
|
|
8,247
|
|
148,528
|
| 3/6/2018 | 2,270 | 40,883 | 6,811 | 122,666 | ||||||
|
Total
|
|
|
|
8,614
|
|
155,138
|
|
25,843
|
|
465,432
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Johan Vandoorn
|
|
3/1/2016
|
|
3,780
|
|
68,078
|
|
11,342
|
|
204,269
|
|
|
|
2/23/2017
|
|
3,087
|
|
55,597
|
|
9,263
|
|
166,827
|
| 3/6/2018 | 2,550 | 45,926 | 7,649 | 137,758 | ||||||
|
Total
|
|
|
|
9,417
|
|
169,601
|
|
28,254
|
|
508,854
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clarence Tse | 2/23/2017 | 2,355 | 42,414 | 7,066 | 127,259 | |||||
| 3/6/2018 | 2,090 | 37,641 | 6,271 | 112,941 | ||||||
|
Total
|
4,445 | 80,055 | 13,337 | 240,200 | ||||||
|
(1)
|
RSUs granted March 1, 2016 cliff-vested on January 1, 2019.
|
|
| (2) |
75% of the RSUs granted in each of 2016, 2017, and 2018 include performance-based vesting criteria. These performance-based RSUs are shown in the column entitled "Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested."
|
|
| (3) |
Based on the closing price of Vishay common stock on December 31, 2018 of $18.01.
|
|
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
|
|
STOCK AWARDS
|
|
|||||
|
|
|
|
NUMBER OF SHARES ACQUIRED ON VESTING
|
|
|
VALUE REALIZED ON VESTING
|
|
||
|
NAME
|
|
|
(#)
|
|
|
($)
|
|
||
|
(a)
|
|
|
(d)
|
|
|
(e)
|
|
||
|
Marc Zandman
|
|
|
|
80,888
|
|
|
|
1,508,561
|
|
|
Dr. Gerald Paul
|
|
|
|
127,647
|
|
|
|
2,380,617
|
|
|
Lori Lipcaman
|
|
|
|
13,345
|
|
|
|
248,883
|
|
|
Johan Vandoorn
|
|
|
|
14,987
|
|
|
|
279,508
|
|
|
2019 Proxy Statement |
Compensation Tables
|
|
|
NAME
(a)
|
|
PLAN NAME
(b)
|
|
NUMBER OF YEARS CREDITED SERVICE
(#)
(c)
|
|
PRESENT VALUE OF ACCUMULATED BENEFIT
(1)
($)
(d)
|
|
PAYMENTS DURING LAST FISCAL YEAR
($)
(e)
|
|
|
Marc Zandman
|
|
Individual contractual post-employment medical arrangement
|
n/a
|
|
182,775
|
|
-
|
|
|
|
|
Individual contractual termination benefits
(3)
|
|
n/a
|
|
6,336,793
|
|
-
|
|
|
|
Dr. Gerald Paul
(2)
|
|
Vishay Europe GmbH Pension Plan and individual contractual arrangement
|
|
n/a
|
|
3,063,723
|
|
-
|
|
|
|
|
Individual contractual post-employment medical arrangement
|
n/a
|
175,964
|
|
-
|
|
||
|
|
|
Individual contractual termination benefits
(3)
|
|
n/a
|
|
7,941,092
|
|
-
|
|
|
Lori Lipcaman
(2)
|
|
Vishay Europe GmbH Pension Plan
|
|
29
|
|
1,533,861
|
|
-
|
|
| Clarence Tse | Executive retirement arrangement | n/a |
-
|
889,400 |
|
(1)
|
These amounts have been calculated using interest rate, mortality, and other actuarial assumptions consistent with those used for financial reporting purposes set forth in Note 11 to Vishay's consolidated financial statements included in our 2018 Annual Report on Form 10-K. | |
| (2) | Dr. Paul's and Ms. Lipcaman's benefits are denominated in euro. Mr. Tse's benefits are denominated in Taiwan dollars. The U.S. dollar amounts shown in the table is based on the weighted average conversion rate for 2018. | |
| (3) | These termination benefits are payable upon normal retirement and accordingly the present value is included in this table. See "Potential Payments Upon Termination or a Change in Control." | |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
NAME
(a)
|
EXECUTIVE CONTRIBUTIONS IN LAST FISCAL YEAR
($)
(b)
|
|
REGISTRANT CONTRIBUTIONS IN LAST FISCAL YEAR
(1)
($)
(c)
|
|
AGGREGATE EARNINGS IN LAST FISCAL YEAR
($)
(d)
|
|
AGGREGATE WITHDRAWALS/DISTRIBUTIONS
($)
(e)
|
|
AGGREGATE BALANCE AT LAST FISCAL YEAR END
($)
(f)
|
|
|||||||||||
|
|
|
|
|
|
|
||||||||||||||||
|
Marc Zandman
|
|
|
-
|
|
|
|
100,000
|
|
|
|
(154,749
|
)
|
|
|
-
|
|
|
|
2,294,024
|
|
|
|
Dr. Gerald Paul
|
|
|
-
|
|
|
|
100,000
|
|
|
|
21,696
|
|
|
|
-
|
|
|
|
1,589,565
|
|
|
|
(1)
|
These amounts are included in column (i) of the "Summary Compensation Table" as a component of "All Other Compensation." No portion of the earnings credited during 2018 was "above market" or "preferential." Accordingly, no amounts related to earnings on deferred compensation have been included in the "Summary Compensation Table." | |
|
•
|
salary continuation for three years, payable over three years;
|
|
•
|
5,000 shares of common stock annually for three years. Because these shares are granted after termination of employment, actual shares – rather than phantom stock units – are granted;
|
|
•
|
bonus for the year of termination;
|
|
•
|
$1,500,000 lump sum cash payment. This payment replaces the annual deferred compensation credits and the annual bonus for the 3-year severance period;
|
|
•
|
lifetime continuation of executive's life insurance benefit. In lieu of insurance, the Company has assumed this obligation; |
|
•
|
the immediate vesting of the executive's outstanding RSUs and the outstanding PBRSUs shall vest on their normal vesting date to the extent applicable performance criteria are realized (provided that upon a change in control, the outstanding PBRSUs would immediately vest as if the performance criteria had been satisfied); and |
|
•
|
continuation of executive's medical benefit for a maximum of three years if the termination occurs before attaining age 62 and lifetime continuation up to $15,000 annual premium value if the termination occurs after attaining age 62. |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
•
|
continuation of base salary for 36 months;
|
|
•
|
payment of any earned but unpaid bonus for the previously completed year; and
|
|
•
|
payment of a pro-rata bonus for the year of termination, based on that year's actual performance.
|
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
SALARY CONT.
(1)
|
BONUS
(2)
|
STOCK GRANTS
(3)(4)
|
LUMP SUM TERMINATION PAYMENT
|
PENSION
(5)
|
MEDICAL BENEFIT
(5)
|
NON-QUALIFIED DEFERRED COMPENSATION
(6)
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Marc Zandman
|
$
|
3,010,325
|
$
|
3,010,325
|
$
|
4,227,686
|
$
|
1,500,000
|
$
|
-
|
$
|
182,775
|
$
|
2,294,024
|
||||||||||||||
|
Dr. Gerald Paul
|
3,541,342
|
3,541,342
|
5,828,432
|
1,500,000
|
3,063,723
|
175,964
|
1,589,565
|
|||||||||||||||||||||
|
Lori Lipcaman
|
1,482,681
|
-
|
620,570
|
-
|
1,533,861
|
-
|
-
|
|||||||||||||||||||||
|
Johan Vandoorn
|
1,665,183
|
-
|
678,455
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
| Clarence Tse |
1,752,834
|
- |
320,255
|
- |
-
|
- | - | |||||||||||||||||||||
|
(1)
|
Equals 3 times U.S. dollar value of the 2018 salary. | |
| (2) | Consists of non-equity incentive plan compensation for 2018 as reflected in the "Summary Compensation Table." | |
| (3) | For Mr. Zandman and Dr. Gerald Paul, includes 15,000 shares, multiplied by $18.01, which was the closing price of Vishay's common stock on December 31, 2018. The shares are to be paid out over three years. | |
| (4) | Includes the value of RSUs outstanding as of December 31, 2018, including PBRSUs, and assumes all performance criteria will be met. | |
| (5) | Present value of accumulated benefit reflected in the "Pension Benefits" table, paid annually until death, exclusive of contractual termination payments for Dr. Paul and Mr. Zandman. | |
| (6) | Aggregate balance at year end as reflected in the "Non-qualified Deferred Compensation" table. | |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
NAME
|
|
UNVESTED TIME-VESTED RSUs
|
|
|
UNVESTED
PBRSUs
|
|
|||
|
Marc Zandman
|
|
|
54,935
|
|
|
|
164,806
|
|
|
|
Dr. Gerald Paul
|
|
|
77,155
|
|
|
|
231,467
|
|
|
|
Lori Lipcaman
|
|
|
8,614
|
|
|
|
25,843
|
|
|
|
Johan Vandoorn
|
|
|
9,417
|
|
|
|
28,254
|
|
|
| Clarence Tse |
4,445
|
13,337
|
|||||||
|
NAME
|
PHANTOM STOCK UNITS
|
VALUE
|
|||||||
|
Marc Zandman
|
84,795
|
$
|
1,527,158
|
||||||
|
Dr. Gerald Paul
|
84,795
|
$
|
1,527,158
|
||||||
|
2019 Proxy Statement |
Compensation Tables
|
|
|
NAME
|
2019 BASE SALARY
(1)
|
|
|
Marc Zandman
|
ILS 3,748,954 (approximately $1,060,000)
(2)
|
|
|
Dr. Gerald Paul
|
€1,039,464 (approximately $1,230,000)
(3)
|
|
|
Lori Lipcaman
|
€435,200 (approximately $510,000)
(3)
|
|
|
Johan Vandoorn
|
€488,769 (approximately $580,000)
(3)
|
|
|
David Valletta
|
$532,916
|
|
| Clarence Tse | TWD 18,320,880 (approximately $610,000) (4) | |
| Joel Smejkal | $348,511 | |
| Werner Gebhardt | €252,452 (approximately $300,000) (3) |
|
(1)
|
The amounts shown have been converted into U.S. dollars at the weighted average exchange rate for 2018. | |
| (2) | Paid in Israeli shekels. | |
| (3) | Paid in euro. | |
| (4) | Paid in Taiwan dollars. | |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
NAME
|
|
TIME-VESTED RSUs
(1)
|
|
PBRSUs
(2)
|
|
TOTAL
|
|
Marc Zandman
|
|
18,108
|
|
54,323
|
|
72,431
|
|
Dr. Gerald Paul
|
|
25,562
|
76,687
|
|
102,249
|
|
|
Lori Lipcaman
|
|
2,854
|
8,562
|
|
11,416
|
|
|
Johan Vandoorn
|
|
3,205
|
|
9,616
|
|
12,821
|
|
David Valletta
|
2,959
|
8,877
|
11,836
|
|||
|
Clarence Tse
|
2,530
|
7,592
|
10,122
|
|||
|
Joel Smejkal
|
|
1,451
|
|
4,354
|
|
5,805
|
|
Werner Gebhardt
|
|
1,242
|
|
3,725
|
|
4,967
|
|
(1)
|
Vest on January 1, 2022. | |
| (2) | Vest at the conclusion of the three-year period if certain defined performance criteria are realized, as determined by the Compensation Committee. | |
|
2019 Proxy Statement |
Compensation Tables
|
|
|
|
NUMBER OF SHARES OF COMMON STOCK TO BE ISSUED UPON EXERCISE OF OUTSTANDING OPTIONS, WARRANTS AND RIGHTS
|
WEIGHTED-AVERAGE EXERCISE PRICE OF OUTSTANDING OPTIONS, WARRANTS AND RIGHTS
|
NUMBER OF SHARES OF COMMON STOK REMAINING AVAILABLE FOR FUTURE ISSUANCE UNDER EQUITY COMPENSATION PLANS (EXCLUDING SHARES REFLECTED IN THE FIRST COLUMN)
|
||||||||||
|
Equity compensation plans approved by stockholders
(1)
|
|||||||||||||
|
|
|||||||||||||
|
2007 Stock Incentive Program
(2)
|
|||||||||||||
|
Restricted Stock Units
(3)
|
904,000
|
n/a
|
(2)
|
||||||||||
|
Phantom Stock Units
(4)
|
170,000
|
n/a
|
(2)
|
||||||||||
|
Total 2007 Stock Incentive Program
|
1,074,000
|
2,894,000
|
|||||||||||
|
|
|||||||||||||
|
Total approved by stockholders
|
1,074,000
|
2,894,000
|
|||||||||||
|
|
|||||||||||||
|
Equity compensation plans not approved by stockholders
|
-
|
-
|
|||||||||||
|
Total equity compensation plans
|
1,074,000
|
2,894,000
|
|||||||||||
|
(1)
|
Additional information about these plans is presented in Note 12 to the Company's consolidated financial statements, which are included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. | |
| (2) | The 2007 Program provides for the grant of stock options, restricted stock, unrestricted stock, RSUs (including PBRSUs), and phantom stock units. Therefore the shares available for future issuance are presented only in total for the program. | |
| (3) |
Each RSU entitles the recipient to receive a share of Vishay common stock. Because these awards have no exercise price, there is no calculation of weighted average exercise price.
|
|
| (4) | Each phantom stock unit entitles the recipient to receive a share of Vishay common stock at the individual's termination of employment or any other future date specified in the employment agreement. Because these awards have no exercise price, there is no calculation of the weighted average exercise price. | |
|
2019 Proxy Statement |
Proposal Three
|
|
|
The Board of Directors recommends that you vote FOR approval of the compensation of our Named Executive Officers as disclosed in the Compensation Discussion and Analysis, the compensation tables, and the related disclosure contained in the proxy statement.
|
|
2019 Proxy Statement |
Proposal Four
|
|
|
·
|
annually
|
|
·
|
biannually; or
|
|
·
|
triennially."
|
|
The Board of Directors recommends that you vote to hold an advisory vote on executive compensation ANNUALLY.
|
|
2019 Proxy Statement |
Certain Relationships and Related Transactions
|
|
|
•
|
the extent of the related person's interest in the transaction and the materiality of the transaction to the Company;
|
|
•
|
the benefits to the Company of the transaction;
|
|
•
|
the availability of other sources of comparable products or services; and
|
|
•
|
the commercial reasonableness of the transaction. |
|
2019 Proxy Statement |
About the Meeting
|
|
|
•
|
FOR
ALL
the nominees for election as Class I (terms expiring 2022) and Class II (term expiring 2020) directors (see Proposal One);
|
|
•
|
FOR
the ratification of Ernst & Young as our independent registered public accounting firm (see Proposal Two);
|
|
•
|
FOR
the advisory approval of executive compensation (see Proposal Three); and
|
|
•
|
FOR
an
ANNUAL
advisory vote on executive compensation (see Proposal Four).
|
|
2019 Proxy Statement |
About the Meeting
|
|
|
•
|
Proposal One.
The election of three directors to hold office for terms of three years and one director to hold office for a term of one year, or until their successors are duly elected and qualified requires a plurality of the votes of the shares of common stock and Class B common stock, voting together as a single class, present in person or presented by proxy and voted on the election of directors.
|
|
•
|
Proposal Two.
The ratification of the appointment of Ernst & Young LLP as Vishay's independent registered public accounting firm for the year ending December 31, 2019 requires a majority of the votes of the shares of common stock and Class B common stock, voting together as a single class, present in person or represented by proxy and voted on the ratification of the appointment of Ernst & Young LLP.
|
|
•
|
Proposal Three. The advisory approval of the compensation of the Company's executive officers as disclosed in the "Compensation and Discussion Analysis" section of this proxy statement requires a majority of the votes of the shares of common stock and Class B common stock, voting together as a single class, present in person or represented by proxy and voted on the advisory approval of the compensation of the Company's executive officers. |
|
•
|
Proposal Four. The advisory vote on the frequency of the advisory vote on executive compensation requires a majority of the votes of the shares of common stock and Class B common stock, voting together as a single class, present in person or represented by proxy. If none of the alternatives receive a majority vote, the frequency selected by stockholders on an advisory basis will be determined by a plurality of votes. |
|
2019 Proxy Statement |
About the Meeting
|
|
|
•
|
If you elected to receive hardcopy proxy materials, please complete, date, and sign the proxy card included in the materials sent to you and return it without delay in the provided envelope, which requires no additional postage if mailed in the United States.
|
|
•
|
If you are enrolled in our electronic proxy materials delivery service and received these proxy materials via the Internet, you will need to follow the procedures for online voting in order to vote your shares.
|
|
•
|
You can vote using a touch-tone telephone by calling 1-800-690-6903, 24 hours a day, seven days a week, and following the instructions on your proxy card.
|
|
•
|
You may also vote by written ballot at the annual meeting. |
|
2019 Proxy Statement |
About the Meeting
|
|
|
•
|
sign and timely return another proxy card bearing a later date;
|
|
•
|
provide written notice of the revocation to Vishay's Corporate Secretary; or
|
|
•
|
attend the annual meeting and vote in person.
|
|
2019 Proxy Statement |
Other Matters
|
|
|
|
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. Eastern Time on May 13, 2019 for shares held directly and by 11:59 P.M. Eastern Time on May 9, 2019 for shares held in a stock brokerage account or by a bank or other nominee. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
|
|
|
|
|
|
VISHAY INTERTECHNOLOGY, INC.
59 MAIDEN LANE
NEW YORK, NY 10038
|
|
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
|
|
|
|
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. Eastern Time on May 13, 2019 for shares held directly and by 11:59 P.M. Eastern Time on May 9, 2019 for shares held in a stock brokerage account or by a bank or other nominee. Have your proxy card in hand when you call and then follow the instructions.
|
|
|
|
|
|
|
|
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
|
|
|
|
|
E67034-P20171
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
DETACH AND RETURN THIS PORTION ONLY
|
||
|
VISHAY INTERTECHNOLOGY, INC.
The Board of Directors recommends that you vote FOR ALL of the following:
|
For
All
|
Withhold
All
|
For All
Except
|
To withhold authority to vote for any individual nominee(s), mark "For All Except" and write the number(s) of the nominee(s) on the line below.
|
|
|
|||
|
1.
|
Election of Directors
Nominees for 3-year terms
01)Dr. Gerald Paul
02)Timothy V. Talbert
03)Thomas C. Wertheimer
|
○
|
○
|
○
|
|
|
|
|
|
|
|
|
|
|||||||
|
Nominee for 1-year term
04)Michael Cody
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|||
|
The Board of Directors recommends you vote FOR the following proposals:
|
|
For
|
Against
|
Abstain
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
To ratify the appointment of Ernst & Young LLP as Vishay's independent registered public accounting firm for the year ending December 31, 2019.
|
○
|
○
|
○
|
|||||
| 3. |
The advisory approval of the compensation of the Company's executive officers.
|
○
|
○
|
○
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommend that an advisory vote on the compensation of the Company's executive officers be held Annually (1 Year):
|
1 Year | 2 Years | 3 Years |
Abstain
|
|||||
| 4. | Frequency of advisory vote on the compensation of the Company's executive officers. |
○
|
○
|
○
|
○
|
||||
|
NOTE:
Such other business as may properly come before the meeting or any adjournment thereof.
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
For address change/comments, mark here. (see reverse for instructions)
|
|
|
|
○
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Yes
|
No
|
|
|
|
|
|
|
|
Please indicate if you plan to attend this meeting.
|
|
○
|
○
|
|
|
|
|
|
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
|
|
Signature (Joint Owners)
|
Date
|
|
||
|
|
VISHAY INTERTECHNOLOGY, INC.
|
|
|
|
2019 Annual Meeting of Stockholders
|
|
|
|
The undersigned hereby appoints Marc Zandman, Dr. Gerald Paul, and Lori Lipcaman, and each of them acting individually, with full power of substitution, to vote all shares of common stock and Class B common stock of Vishay Intertechnology, Inc. which the undersigned is entitled to vote at the Annual Meeting of Stockholders of Vishay Intertechnology, Inc. to be held at the Vishay Intertechnology, Inc. World Headquarters, 63 Lancaster Avenue, Malvern, PA 19355, at 9:30 a.m., local time, on Tuesday, May 14, 2019, and at any adjournment thereof, hereby ratifying all that said proxies or their substitutes may do by virtue hereof, and the undersigned authorizes and instructs said proxies to vote as indicated on the reverse side:
|
|
|
|
|
|
|
|
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations.
|
|
|
|
|
|
|
|
PLEASE DATE, SIGN AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.
|
|
|
|
|
|
|
|
Address Changes/Comments :
|
|
|
|
|
|
|
|
|
|
|
|
(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.)
|
|
|
|
|
|
|
|
(Continued and to be dated and signed on the other side.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|